6
11
Ṁ57Ṁ370
2027
35%
chance
1D
1W
1M
ALL
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of squamous cell carcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.
Get Ṁ200 play money
More related questions
Related questions
Will the FDA approve a disease-modifying treatment for Parkinson's disease before 2029?
59% chance
Will FDA approve any mRNA vaccine against any strain of influenza before 2028?
78% chance
Will FDA approve any mRNA vaccine against malaria before 2028?
45% chance
Will FDA approve any mRNA vaccine against any type of breast cancer before 2028?
29% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
63% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will FDA approve any mRNA vaccine against lymphoblastic leukemia before 2028?
34% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
38% chance
Will the FDA issue an EUA or full approval for an mRNA H5N1 vaccine by 2025?
28% chance
Will FDA approve any mRNA vaccine against AIDS before 2028?
24% chance